Low T Lawsuits: October Case Management Conference
Low T Lawsuits: Case Management Conferences
Important updates on the low t lawsuits vs. testosterone therapy drug manufacturers, including details on the upcoming October case management conference.According to information from the United States District Court in the Northern District of Illinois, another case management conference for MDL 2545 is scheduled to be held on October 15th, 2015 at 3:30pm. This case management conference will follow one that took place on September 17th.
At the conference, it is anticipated that attorneys for both the defendants and the plaintiffs will discuss several notable issues with the court pertaining to the status of selection of the cases for bellwether trials. The pending low testosterone lawsuits allege that testosterone therapy drugs have caused their male patients to suffer from a number of dangerous health conditions, including blood clots, strokes, heart attacks, and even death.
Who Is Being Sued In The Low Testosterone Lawsuits?
Currently, multiple testosterone drug manufacturers have been named in the suit. Among those named are AbbVie Inc., Abbott Laboratories, Ely Lilly, and Endo Pharmaceuticals. Together, these companies produce a variety of low testosterone drugs, including AndroGel, Fortesta, Delatestryl, and Axiron. All complaints have been consolidated to form a multidistrict litigation (MDL No.2545) in the U.S. District Court in the Northern District of Illinois. Currently, this consists of almost 2,500 plaintiffs. The trials will be overseen by Judge Matthew F. Kennelly.
What do the Low T Lawsuits Allege?
The pending litigation alleges that male patients who were prescribed low testosterone drugs to treat their lowering testosterone levels suffered from serious side effects including heart attacks, blood clots, strokes, and death. Claims also allege that the companies manufacturing these drugs were aware of these serious complications, yet neglected to properly warn consumers about them. Additionally, advertising tactics have come under scrutiny, as it has been indicated that they use aggressive tactics and cause men who do not have diagnosed conditions to think that they also need low testosterone therapy due to normal symptoms associated with aging.
Low Testosterone drug use has significantly increased in recent years. As men age, their testosterone levels naturally lower, causing unpleasant side effects that can include: decreased sex drive, muscle mass, and bone mass, and increased weight and mood swings, among other things. While the FDA has approved use of low testosterone drugs for men with specific diagnosed conditions such as hypogonadism, this does not encompass men experiencing normal and typical symptoms of aging.
Where Can I Find Legal Support?
As lawsuits continue to join MDL 2545 in recent months, more men learn about the allegations connected to low testosterone drugs.
“Banville Law Firm is currently helping individuals and their families who are looking into their legal rights in the testosterone litigation,” said Laurence Banville, Esq. of Banville Law.
“If you or a loved one have suffered from health implications after being prescribed a low testosterone therapy drug, you may be eligible to take legal action,” he continued.
In addition to assisting those looking into their rights concerning this litigation, Banville sponsors the online resource center LowTestosteroneCase.com, which is dedicated to providing important information for anyone further researching this topic.
To speak with Laurence Banville, Esq., please call 917-809-6595 at anytime.